Cordis receives FDA approval for MYNX CONTROL™ VENOUS VCD. Read More
Mar 17, 2022
The Radianz Radial Peripheral System(TM); signals Cordis’ renewed investment in innovation
Read more
Jan 5, 2022
Cordis, a global interventional cardiovascular technology company, today announced that Christopher Scully has joined the organization as Chief Finan...
Dec 8, 2021
Matthew Muscari takes the helm of global marketing and American sales as Cordis pursues path of transformation and growth
Mar 12, 2021
Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion...